Umbilical cord blood plasma contains soluble NKG2D ligands that mediate loss of natural killer cell function and cytotoxicity

NK cells play a key role in innate elimination of virally infected or neoplastic cells but they can be circumvented by immunoevasive mechanisms enabling viral spread or tumor progression. Engagement of the NKG2D activating receptor with soluble forms of its ligand is one such mechanism of inducing NK cell hyporesponsiveness. Interestingly, this immunoevasive strategy among others is described at the maternal‐fetal interface where tolerance of the semi‐allogeneic fetus is required to allow successful human pregnancy. Understanding of maternal‐fetal tolerance is increasing but mechanisms preventing alloreactivity of fetal immune cells against the maternal host are less well understood. The study of umbilical cord blood has enabled insight of the fetal immune system, which appears immature and inert. We have found that soluble NKG2D ligands (sNKG2DLs) are present in cord blood plasma (CBP) and associate with adult NK cell hyporesponsiveness demonstrated by reduced CD107a expression and secretion of IFN‐γ upon stimulation. The capacity of NK cells to kill K562 cells or proliferate was also reduced by incubation with CBP; however, physical removal of sNKG2DL from CBP restored K562 lytic function and NKG2D expression. Therefore, our results strongly suggest sNKG2DLs are expressed in CBP as a mechanism of fetal‐maternal tolerance in human pregnancy.

[1]  W. Burlingham,et al.  Non-inherited maternal antigens, pregnancy, and allotolerance , 2015, Biomedical journal.

[2]  K. Yoon.  Use of Umbilical Cord Serum in Ophthalmology , 2014, Chonnam medical journal.

[3]  J. Madrigal,et al.  Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes. , 2014, Tissue antigens.

[4]  A. Santoni,et al.  c‐Cbl regulates MICA‐ but not ULBP2‐induced NKG2D down‐modulation in human NK cells , 2014, European journal of immunology.

[5]  J. Madrigal,et al.  Further polymorphism of the RAET1E/ULBP4 gene in humans. , 2014, Tissue antigens.

[6]  J. Madrigal,et al.  RAET1/ULBP alleles and haplotypes among Kolla South American Indians. , 2013, Human immunology.

[7]  A. Madrigal,et al.  Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy , 2013, Cellular and Molecular Immunology.

[8]  S. Gasser,et al.  Regulation of ligands for the NKG2D activating receptor. , 2013, Annual review of immunology.

[9]  O. Levy,et al.  Plasma‐mediated immune suppression: a neonatal perspective , 2013, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[10]  A. Erlebacher.  Mechanisms of T cell tolerance towards the allogeneic fetus , 2012, Nature Reviews Immunology.

[11]  J. Madrigal,et al.  Three novel allelic variants of the RAET1E/ULBP4 gene in humans. , 2012, Tissue antigens.

[12]  S. Khakoo,et al.  The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. , 2012, Human immunology.

[13]  Baptiste N. Jaeger,et al.  Natural killer cell tolerance: control by self or self-control? , 2012, Cold Spring Harbor perspectives in biology.

[14]  Binqing Fu,et al.  TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence , 2012, PLoS pathogens.

[15]  Chia-Li Yu,et al.  The alteration of placental‐derived soluble MHC class I chain‐related protein A and B during pregnancy , 2011, Acta obstetricia et gynecologica Scandinavica.

[16]  L. Lynch,et al.  Natural Killer Cells in Psoriasis , 2011, Journal of Innate Immunity.

[17]  P. Moss,et al.  Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations. , 2010, Human immunology.

[18]  L. Lanier,et al.  Effect of NKG2D ligand expression on host immune responses , 2010, Immunological reviews.

[19]  J. Trowsdale,et al.  ULBP6/RAET1L is an additional human NKG2D ligand , 2009, European journal of immunology.

[20]  H. Inoko,et al.  Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in Northeastern Thais , 2009, Immunogenetics.

[21]  L. Mincheva-Nilsson,et al.  Human Placenta Expresses and Secretes NKG2D Ligands via Exosomes that Down-Modulate the Cognate Receptor Expression: Evidence for Immunosuppressive Function1 , 2009, The Journal of Immunology.

[22]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[23]  R. Paus,et al.  Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. , 2008, The Journal of investigative dermatology.

[24]  L. Lanier.  Evolutionary struggles between NK cells and viruses , 2008, Nature Reviews Immunology.

[25]  T. Heidmann,et al.  Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins , 2007, Proceedings of the National Academy of Sciences.

[26]  R. Sun,et al.  High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. , 2007, Cellular & molecular immunology.

[27]  L. Mincheva-Nilsson,et al.  Placenta-Derived Soluble MHC Class I Chain-Related Molecules Down-Regulate NKG2D Receptor on Peripheral Blood Mononuclear Cells during Human Pregnancy: A Possible Novel Immune Escape Mechanism for Fetal Survival1 , 2006, The Journal of Immunology.

[28]  J. Blay,et al.  CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner , 2005, The Journal of experimental medicine.

[29]  B. O'Malley,et al.  Inhibition of NK Cell Activity through TGF-β1 by Down-Regulation of NKG2D in a Murine Model of Head and Neck Cancer1 , 2005, The Journal of Immunology.

[30]  H. Inoko,et al.  MIC and other NKG2D ligands: from none to too many. , 2005, Current opinion in immunology.

[31]  M. Duval,et al.  Characterization of Cord Blood Natural Killer Cells: Implications for Transplantation and Neonatal Infections , 2005, Pediatric Research.

[32]  Jessica M Malenfant,et al.  CD107a as a functional marker for the identification of natural killer cell activity. , 2004, Journal of immunological methods.

[33]  A. Moffett,et al.  Human uterine leukocytes and pregnancy. , 2004, Tissue antigens.

[34]  D. Raulet.  Roles of the NKG2D immunoreceptor and its ligands , 2003, Nature Reviews Immunology.

[35]  A. Moffett-King.  Natural killer cells and pregnancy , 2002, Nature Reviews Immunology.

[36]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[37]  S. Guller,et al.  The Role of Placental Fas Ligand in Maintaining Immune Privilege at Maternal - Fetal Interfaces , 1999, Seminars in reproductive endocrinology.

[38]  Statistical Tests for Signals in Categorial Temporal Data , 1996 .

[39]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[40]  C. Walker,et al.  Immunoregulatory molecules of trophoblast and decidual suppressor cell origin at the maternofetal interface. , 1986, American journal of reproductive immunology and microbiology : AJRIM.

[41]  L. Brent,et al.  Suppression of natural cell-mediated cytotoxicity in man by maternal and neonatal serum. , 1982, Clinical and experimental immunology.

[42]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.